Pure Cycle Technologies opened lower at $1.96, compared with its previous close of $2.00. In the last trading session, the stock traded between $1.79 and $1.96. It showed a downward intraday trend.
An investment of $100 made 5 years ago in Pure Cycle Technologies is now worth
$ 18.35
Resulting in a loss of
$ 81.65 (81.65%)
Note: Past profits do not guarantee future returns.
Rating from 4 Analysts
Today's Change
$-0.20 (-10.20%)
Day High
$1.96
Day Low
$1.79
Day Open
$1.96
Prev Close
$2.00
Volume
55,37,401
1W Return
-35.23%
1M Return
-50.04%
3M Return
-76.52%
6M Return
-81.84%
1Y Return
-81.84%
Market Cap ($ Mn)
361
PE Ratio
-
PB Ratio
84.17
PEG Ratio
-
ROE
-144.52%
ROCE
-15.36%
EPS (TTM)
$0.00
1 Week
-35.23%
1 Month
-50.04%
3 Months
-76.52%
6 Months
-81.84%
9 Months
-80.15%
SBS investigates PureCycle Technologies over securities law claims
Schall, Brown & Schwartz LLP is investigating PureCycle Technologies for securities law violations. Investigation triggered by Q3 results reported on November 4, 2026. Company disclosed sharp revenue decline and reliability issues at Ironton plant. Share price fell sharply following the release of these financial results.
4 days agoPureCycle Technologies appoints Fernando Musa as Executive Chairman
Fernando Musa appointed Executive Chairman effective November 3, 2026. Term of appointment extends through December 31, 2027. Dan Coombs steps down from the Chairman role.
8 days agoPureCycle Technologies Q3 revenue falls to $2.3 million on operational delays
Revenue fell to $2.3 million in Q3 from $4.5 million in Q2 due to plant reliability issues and New Jersey regulatory delays. Net income reached $6.9 million, driven by a $58.6 million non-cash gain on warrant fair value changes, despite a $37.5 million operating loss. Monthly operations spending decreased to $7.8 million, below the guided range, as the company brought more maintenance work in-house. Qualified applications doubled to 20, with new contracts like the WM feedstock agreement securing up to 25 million pounds of supply annually.
8 days agoPureCycle Technologies Q3FY26 Results: Earnings call set for Nov 4
PureCycle Technologies will report Q3FY26 results on November 4, 2026. Conference call scheduled for 5:00 pm EST on the same day. Replay available until February 4, 2027. Results cover the quarter ended September 30, 2026.
22 days agoPureCycle Technologies Q2 Results: Adj. EPS Misses Estimate
PureCycle Technologies missed Q2 analyst estimates with an adjusted EPS of $(0.33) versus $(0.29) expected, and sales of $4.512M versus $6.104M expected. However, sales rose 173.45% YoY from $1.650M, and losses narrowed significantly from $(0.81) per share in the prior year.
3mo agoPureCycle closes $432.5M offerings to cut debt
PureCycle Technologies closed its concurrent public offerings of $287.5 million in 4.75% convertible senior notes due 2032 and 19,854,000 shares of common stock, raising aggregate net proceeds of approximately $432.5 million. The company plans to use approximately $246.3 million to repurchase $216.0 million in aggregate principal amount of its outstanding 7.25% Green Convertible Senior Notes due 2030. The remaining proceeds will be used for additional repurchases of Green Convertible Notes, working capital, and general corporate purposes.
5mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $808.24 | +1.41% | $2,13,922.54M | 26.14 | |
| $360.62 | +1.81% | $1,40,100.87M | 40.97 | |
| $972.90 | +0.80% | $1,22,679.77M | 34.94 | |
| $167.06 | -0.29% | $91,649.12M | 33.96 | |
| $288.72 | +0.23% | $82,054.22M | 25.39 | |
| $206.51 | +6.33% | $79,518.74M | 58.16 | |
| $463.26 | +2.00% | $63,502.75M | 28.86 | |
| $209.47 | +12.97% | $61,931.27M | 277.33 | |
| $239.69 | +0.58% | $54,965.23M | 34.54 | |
| $406.19 | +2.27% | $45,106.99M | 40.34 | |
| $85.06 | -0.93% | $32,664.74M | 32.34 | |
| $77.50 | -0.81% | $29,505.10M | 18.44 |
An investment of $100 made 5 years ago in Pure Cycle Technologies is now worth
$ 18.35
Resulting in a loss of
$ 81.65 (81.65%)
Note: Past profits do not guarantee future returns.
